Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 424B3 Offering Prospectus
  7. 8-K Event Other events
  8. 425 Deal Prospectus/Communication re Business Combination
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 425 Deal Prospectus/Communication re Business Combination
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 424B3 Offering Prospectus
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 10-Q Report Quarterly Report
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 8-K Event Results of operations
  17. CT ORDER Other Confidential Order
  18. 424B3 Offering Prospectus
  19. EFFECT Other Notice of Effectiveness
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 24 of 64 · 1,276 filings